Literature DB >> 3733227

Comparative in vitro activity of cefpirome (HR 810) against gram-positive isolates from cancer patients.

K V Rolston, G P Bodey.   

Abstract

The activity of cefpirome against gram-positive isolates from cancer patients was compared to that of currently available extended-spectrum cephalosporins. Cefpirome was active against methicillin-susceptible, coagulase-positive, and coagulase-negative staphylococci. It was the most active agent against streptococci belonging to Lancefield groups A, B and G and Streptococcus pneumoniae. 76% of enterococcal isolates were susceptible to cefpirome - far more than any of the other agents tested.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733227     DOI: 10.1007/bf01643480

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  The antimicrobial activity of cefpirome, a new cephalosporin.

Authors:  R Wise; J M Andrews; C Cross; L J Piddock
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

2.  Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

Authors:  V L Yu
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

3.  New beta-lactam antibiotics in granulocytopenic patients. New options and new questions.

Authors:  P A Pizzo; M Thaler; J Hathorn; J Hiemenz; J Skelton; J McKnight; M Rubin; M Browne; D Longo; D Cotton
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

4.  Single-agent therapy for infections in neutropenic cancer patients.

Authors:  V Fainstein; G P Bodey
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

5.  In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.

Authors:  R N Jones; C Thornsberry; A L Barry
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

6.  Species dependent variability in the susceptibility of coagulase-negative staphylococci to various antimicrobial agents.

Authors:  K V Rolston; P Thirolf; D S Ho; G P Bodey
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

7.  Nosocomial infections in the immunocompromised adult.

Authors:  L S Young
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

8.  In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.

Authors:  P H Chandrasekar; S Price; D P Levine
Journal:  J Antimicrob Chemother       Date:  1985-08       Impact factor: 5.790

9.  Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria.

Authors:  C Thornsberry
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

10.  Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia.

Authors:  J C Wade; S C Schimpff; K A Newman; P H Wiernik
Journal:  Ann Intern Med       Date:  1982-10       Impact factor: 25.391

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.